NICE approves eltrombopag for NHS use

NICE has ruled that eltrombopag (Revolade) can be considered for the treatment of chronic immune (idiopathic) thrombocytopenic purpura (ITP) within its marketing authorisation, following a review of its 2010 guidance.

Eltrombopag is an oral thrombopoietin receptor agonist that increases platelet counts by stimulating the differentiation and proliferation of megakaryocytes | SCIENCE PHOTO LIBRARY
Eltrombopag is an oral thrombopoietin receptor agonist that increases platelet counts by stimulating the differentiation and proliferation of megakaryocytes | SCIENCE PHOTO LIBRARY

To be eligible for treatment, the patient must either be refractory to standard active treatments and rescue therapies or have severe ITP and a high risk of bleeding that needs frequent course of rescue therapies. 

The NICE recommendations are made on the proviso that the manufacturer provides eltrombopag with the discount agreed in the patient access scheme.

View Revolade drug record

NICE guidance on eltrombopag for treating chronic immune (idiopathic) thrombocytopenic purpura (review of technology appraisal 205).

Follow MIMS on Twitter


MIMS Clinics

Prescribing news and resources for key therapeutic areas, collated by the MIMS editors.

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS bulletins

News and updates straight to your inbox.

Prescribing Update: Fortnightly news bulletin
Alert:
Urgent prescribing updates
Spotlight: Disease-themed monthly round-up

Sign me up

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases

Promo Image

Clinical calculators

Handy calculators and conversions for primary care.